Invasive Ductal Carcinoma

Invasive Ductal Carcinoma (IDC) is the most common type of breast cancer, accounting for approximately 80% of all breast cancer diagnoses. Despite its prevalence, understanding IDC's complexities can be challenging due to the varying grades, stages, and treatment options available.

What is Invasive Ductal Carcinoma?

Invasive Ductal Carcinoma begins in the milk ducts of the breast and invades surrounding tissue. Unlike non-invasive breast cancers, IDC has the potential to spread (metastasize) to other parts of the body, making early detection and treatment crucial.

Secure your health with a second opinion. Make informed decisions and book your appointment today!

Get A Second Opinion

Types of Invasive Ductal Carcinoma

There are several types of IDC, each with unique characteristics:

Tubular Carcinoma: Generally small, slow-growing, and has a good prognosis.
Medullary Carcinoma: Often presents as a well-defined mass and may have a better prognosis than other IDC types.
Mucinous Carcinoma: Characterized by mucus production within the tumour, typically has a favourable outlook.
Papillary Carcinoma: Rare and tends to occur in older women, usually has a good prognosis.
Cribriform Carcinoma: Shows a distinctive pattern under the microscope and generally has a favourable prognosis.

Diagnosis and Differential Diagnosis of IDC

Diagnostic Procedures

Diagnosing IDC involves a combination of imaging tests and biopsies. Common diagnostic procedures include:

Mammography: An X-ray of the breast is used as a primary screening tool.
Ultrasound: Often used to further evaluate abnormalities found in mammograms.
MRI: Provides detailed images and is particularly useful in dense breast tissue.
Biopsy: Involves extracting tissue samples for histological examination to confirm the presence of cancer cells.

Differential Diagnosis

Differential diagnosis is essential to distinguish IDC from other breast conditions. Conditions that may mimic IDC include:

Fibroadenomas: Benign breast tumours.
Ductal Carcinoma In Situ (DCIS): A non-invasive form of cancer confined to the ducts.
Lobular Carcinoma: Begins in the milk-producing lobules and can be invasive or non-invasive.
Benign Breast Disease: Such as cysts or infections that can present with similar symptoms.

Grading and Staging of IDC

Grading and staging are critical in determining the treatment plan and prognosis.

Grading

IDC is graded based on how much the cancer cells resemble normal breast cells:

Grade 1: Well-differentiated, cells look similar to normal cells, and the cancer grows slowly.
Grade 2: Moderately differentiated cells have features between grades 1 and 3.
Grade 3: Poorly differentiated, cells look very different from normal cells, and the cancer grows more aggressively.

Staging

Staging considers the tumour size, lymph node involvement, and metastasis:

Stage 1: The tumor is small and confined to the breast.
Stage 2: The tumor may be larger and/or spread to nearby lymph nodes.
Stage 3: Tumor is large and/or extensively spread to lymph nodes but not to distant organs.
Stage 4: Cancer has spread to distant organs (metastatic cancer).

Treatment Options for IDC

Treatment for IDC depends on the cancer's grade and stage, as well as the patient's overall health.

Invasive Ductal Carcinoma Grade 1 Treatment

For Grade 1 IDC, treatment often involves:

Surgery: Lumpectomy (removal of the tumour) or mastectomy (removal of the breast).
Radiation Therapy: Often follows surgery to destroy any remaining cancer cells.
Hormone Therapy: If the cancer is hormone receptor-positive.

Invasive Ductal Carcinoma Grade 2 Treatment

Grade 2 IDC may require a more aggressive approach:

Surgery: Lumpectomy or mastectomy, depending on the tumour size and location.
Radiation Therapy: Post-surgery to minimize recurrence.
Chemotherapy: May be recommended based on the tumor's characteristics.
Hormone Therapy: For hormone receptor-positive cancers.
Targeted Therapy: For HER2-positive cancers, drugs like trastuzumab may be used.

Ready to take control of your health journey? Book your appointment now and start your path towards wellness today!

Book an Appointment

Invasive Ductal Carcinoma Grade 3 Treatment

Grade 3 IDC requires aggressive treatment due to its rapid growth:

Surgery: Mastectomy is often preferred, but lumpectomy may be an option.
Radiation Therapy: To target remaining cancer cells post-surgery.
Chemotherapy: Almost always recommended to reduce the risk of recurrence.
Hormone Therapy and Targeted Therapy: Depending on receptor status.

Survival Rates

Invasive Ductal Carcinoma Grade 3 Survival Rate

The survival rate for IDC varies based on grade and stage. For Grade 3 IDC, the 5-year survival rate is approximately 72%, but this can vary widely based on factors such as tumour size, lymph node involvement, and the patient's response to treatment.